Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity GlobeNewswire October 21, 2025 Results show maximum placebo-adjusted weight loss of 4.6% with 12% treatment discontinuation due to adverse events Asymptomatic, reversible grade 3 liver enzyme elevations occurred in three participants during post-treatment follow-up period, two […]

Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 21, 2025 CARLSBAD, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2025, before the market opens on Tuesday, November 4,

The Lovesac Company Appoints Jacob Pat as Chief Technology and Digital Transformation Officer Proven Technology Leader to Enhance the Company's Digital Strategies to Support Growth Objectives GlobeNewswire October 21, 2025 STAMFORD, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand

LifeVantage to Announce First Quarter Fiscal Year 2026 Results on November 4, 2025 GlobeNewswire October 21, 2025 SALT LAKE CITY, Oct. 21, 2025 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results

Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 21, 2025 SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for

Xometry to Announce Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 21, 2025 NORTH BETHESDA, Md., Oct. 21, 2025 (GLOBE NEWSWIRE) — Xometry, Inc. (NASDAQ: XMTR), the global AI-powered marketplace connecting buyers and suppliers of custom manufacturing, announced it will report its third quarter 2025 financial results before the market opens on

Beyond Meat(R) to Report Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 21, 2025 EL SEGUNDO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, announced today it will report financial results for the third quarter ended September 27,

Remitly to Report Third Quarter Financial Results on November 5, 2025 GlobeNewswire October 21, 2025 SEATTLE, Oct. 21, 2025 (GLOBE NEWSWIRE) — Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of digital financial services that transcend borders, today announced that it will report third quarter financial results after the market close on Wednesday, November

InspireMD to Announce Third Quarter 2025 Financial Results GlobeNewswire October 21, 2025 MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard(R) Prime carotid stent system for the prevention of stroke, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025. In conjunction

Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update GlobeNewswire October 21, 2025 SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of